Poolbeg Pharma Plc Stock Performance

POLBF Stock  USD 0.07  0.02  55.53%   
On a scale of 0 to 100, Poolbeg Pharma holds a performance score of 10. The company holds a Beta of 0.0155, which implies not very significant fluctuations relative to the market. As returns on the market increase, Poolbeg Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Poolbeg Pharma is expected to be smaller as well. Please check Poolbeg Pharma's jensen alpha, daily balance of power, as well as the relationship between the Daily Balance Of Power and day typical price , to make a quick decision on whether Poolbeg Pharma's historical price patterns will revert.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Poolbeg Pharma PLC are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental drivers, Poolbeg Pharma reported solid returns over the last few months and may actually be approaching a breakup point. ...more
  

Poolbeg Pharma Relative Risk vs. Return Landscape

If you would invest  4.25  in Poolbeg Pharma PLC on November 13, 2025 and sell it today you would earn a total of  2.36  from holding Poolbeg Pharma PLC or generate 55.53% return on investment over 90 days. Poolbeg Pharma PLC is currently producing 0.8956% returns and takes up 7.0522% volatility of returns over 90 trading days. Put another way, 63% of traded pink sheets are less volatile than Poolbeg, and 82% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Poolbeg Pharma is expected to generate 9.07 times more return on investment than the market. However, the company is 9.07 times more volatile than its market benchmark. It trades about 0.13 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

Poolbeg Pharma Target Price Odds to finish over Current Price

The tendency of Poolbeg Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.07 90 days 0.07 
near 1
Based on a normal probability distribution, the odds of Poolbeg Pharma to move above the current price in 90 days from now is near 1 (This Poolbeg Pharma PLC probability density function shows the probability of Poolbeg Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Poolbeg Pharma has a beta of 0.0155 indicating as returns on the market go up, Poolbeg Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Poolbeg Pharma PLC will be expected to be much smaller as well. Additionally Poolbeg Pharma PLC has an alpha of 0.8301, implying that it can generate a 0.83 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Poolbeg Pharma Price Density   
       Price  

Predictive Modules for Poolbeg Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Poolbeg Pharma PLC. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.077.12
Details
Intrinsic
Valuation
LowRealHigh
0.000.057.10
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Poolbeg Pharma. Your research has to be compared to or analyzed against Poolbeg Pharma's peers to derive any actionable benefits. When done correctly, Poolbeg Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Poolbeg Pharma PLC.

Poolbeg Pharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Poolbeg Pharma is not an exception. The market had few large corrections towards the Poolbeg Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Poolbeg Pharma PLC, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Poolbeg Pharma within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.83
β
Beta against Dow Jones0.02
σ
Overall volatility
0
Ir
Information ratio 0.11

Poolbeg Pharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Poolbeg Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Poolbeg Pharma PLC can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Poolbeg Pharma PLC is way too risky over 90 days horizon
Poolbeg Pharma PLC has some characteristics of a very speculative penny stock
Poolbeg Pharma PLC appears to be risky and price may revert if volatility continues
Poolbeg Pharma PLC has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (3.11 M) with profit before overhead, payroll, taxes, and interest of 0.
Poolbeg Pharma PLC has accumulated about 18.89 M in cash with (2.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.
Roughly 20.0% of the company outstanding shares are owned by corporate insiders

Poolbeg Pharma Fundamentals Growth

Poolbeg Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Poolbeg Pharma, and Poolbeg Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Poolbeg Pink Sheet performance.

About Poolbeg Pharma Performance

By analyzing Poolbeg Pharma's fundamental ratios, stakeholders can gain valuable insights into Poolbeg Pharma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Poolbeg Pharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Poolbeg Pharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Poolbeg Pharma plc operates as a clinical stage infectious disease pharmaceutical company in the United Kingdom. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom. Poolbeg Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 7 people.

Things to note about Poolbeg Pharma PLC performance evaluation

Checking the ongoing alerts about Poolbeg Pharma for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Poolbeg Pharma PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Poolbeg Pharma PLC is way too risky over 90 days horizon
Poolbeg Pharma PLC has some characteristics of a very speculative penny stock
Poolbeg Pharma PLC appears to be risky and price may revert if volatility continues
Poolbeg Pharma PLC has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (3.11 M) with profit before overhead, payroll, taxes, and interest of 0.
Poolbeg Pharma PLC has accumulated about 18.89 M in cash with (2.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.
Roughly 20.0% of the company outstanding shares are owned by corporate insiders
Evaluating Poolbeg Pharma's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Poolbeg Pharma's pink sheet performance include:
  • Analyzing Poolbeg Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Poolbeg Pharma's stock is overvalued or undervalued compared to its peers.
  • Examining Poolbeg Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Poolbeg Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Poolbeg Pharma's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Poolbeg Pharma's pink sheet. These opinions can provide insight into Poolbeg Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Poolbeg Pharma's pink sheet performance is not an exact science, and many factors can impact Poolbeg Pharma's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Poolbeg Pink Sheet analysis

When running Poolbeg Pharma's price analysis, check to measure Poolbeg Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Poolbeg Pharma is operating at the current time. Most of Poolbeg Pharma's value examination focuses on studying past and present price action to predict the probability of Poolbeg Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Poolbeg Pharma's price. Additionally, you may evaluate how the addition of Poolbeg Pharma to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments